PRostate Cancer Enhanced Diagnosis by Calibration Technology

Not yet recruitingOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Prostate Cancers
Interventions
DIAGNOSTIC_TEST

MRI

Standard MRI using phantom.

Trial Locations (1)

WC1E 6AG

University College Hospital, London

All Listed Sponsors
collaborator

Bioxydyn Ltd, Manchester

UNKNOWN

collaborator

National Cancer Imaging Translational Accelerator

UNKNOWN

collaborator

University College London Hospitals

OTHER

collaborator

National Hospital of Neurology and Neurosurgery, Queens Square, London, UK

UNKNOWN

lead

Gold Standard Phantoms

INDUSTRY